Ledger.Open graph →
SEC Form D · filed February 14, 2014

ContraVir Pharmaceuticals, Inc

Offering
$3.2M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

John P. Brancaccio · New York, NYDirectorTimothy P. Block · New York, NYDirectorBernard F. Denoyer · New York, NYExec · DirectorChristopher P. Mcguigan · New York, NYDirectorGary S. Jacob · New York, NYExec · DirectorRonald Carner · Brooklyn, NYDirectorWalter Klores · Brooklyn, NYDirectorJeffrey S. Serota · Dallas, TXExec · DirectorRobert L. Stillwell · Dallas, TXDirectorHarold L. Hickey · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗